Elizabeth Delaney
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $556 and has fallen 94.0% since, to $33 in 2025.
Across 43 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$124
- Novartis$103
- Pharmacyclics LLC, An Abbvie Company$100
- AstraZeneca$81
- Daiichi Sankyo Inc.$60
- Astellas Pharma US Inc$40
- plus $404 from 18 others
What the payments were for
- Food & beverage$87396%
- Education$404%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 6 | $124 |
| Novartis | 6 | $103 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $100 |
| AstraZeneca | 1 | $81 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Astellas Pharma US Inc | 1 | $40 |
| Tersera Therapeutics LLC | 2 | $35 |
| AbbVie | 1 | $33 |
| Genentech USA, Inc. | 2 | $33 |
| Bayer | 2 | $31 |
| Bristol Myers Squibb | 2 | $29 |
| Beigene USA, Inc. | 1 | $26 |
| GSK | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| ADC Therapeutics America, Inc. | 1 | $20 |
| Gilead | 1 | $19 |
| Pfizer | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
How this compares
$913 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.
Other family in Xenia
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
- Kirt MunsonToledo$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.